Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-13, Stock:TMO, The news for the past five days is as follows:
2019-11-06: NEWS1: CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance.NEWS2: Phibro's (PAHC) Q1 Earnings & Revenues Fall Y/Y, Margins Down.NEWS3: HMS Holdings (HMSY) Q3 Earnings Top Estimates, Revenues Miss.NEWS4: Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3.NEWS5: Zacks.com featured highlights include: SYNNEX, Thermo Fisher Scientific, Allstate, Intel and Target.NEWS6: Inogen's (INGN) Q3 Earnings and Revenues Beat Estimates.NEWS7: DaVita (DVA) Earnings and Revenues Beat Estimates in Q3.NEWS8: STERIS' (STE) Q2 Earnings Surpass Estimates, FY20 View Up.
2019-11-07: NEWS1: Option Care Health (BIOS) Q3 Earnings Meet, Revenues Top.NEWS2: DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Ups '19 View.NEWS3: Globus Medical (GMED) Q3 Earnings Meet Mark, Revenue View Up.NEWS4: Hologic's (HOLX) Q4 Earnings Meet, Revenues Top Estimates.NEWS5: Cardinal Health (CAH) Q1 Earnings & Revenues Beat Estimates.NEWS6: AmerisourceBergen (ABC) Q4 Earnings & Revenues Beat Estimates.NEWS7: Insulet (PODD) Beats on Q3 Earnings, Ups '19 Revenue View.NEWS8: OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat.
2019-11-08: NEWS1: Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?.NEWS2: Nevro (NVRO) Q3 Loss Narrower Than Expected, Revenues Up Y/Y.NEWS3: DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3.NEWS4: Glaukos (GKOS) Q3 Loss Narrower Than Expected, '19 View Up.NEWS5: LHC Group (LHCG) Q3 Earnings Surpass Estimates, Revenues Lag.NEWS6: Thermo Fisher sets new $2.5 billion stock buyback program.NEWS7: National Vision's (EYE) Q3 Earnings Top Estimates, View Raised.NEWS8: Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases.
2019-11-11: NEWS1: Penumbra's (PEN) Q3 Earnings & Revenues Surpass Estimates.
2019-11-12: nan

Answer: Rise